MA17.01 Reduced FEV1 as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors

Category Primary study
JournalJournal of Thoracic Oncology
Year 2021
This article has no abstract
Epistemonikos ID: 07440b2140a73ee003a303d0c071e8c629839673
First added on: Feb 13, 2025